Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5216

1.

Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease.

Knuuti J, Bengel F, Bax JJ, Kaufmann PA, Le Guludec D, Perrone Filardi P, Marcassa C, Ajmone Marsan N, Achenbach S, Kitsiou A, Flotats A, Eeckhout E, Minn H, Hesse B.

Eur Heart J. 2014 Mar;35(10):633-8. doi: 10.1093/eurheartj/eht512. Epub 2013 Dec 29. No abstract available.

PMID:
24375074
2.

High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression.

Youker KA, Assad-Kottner C, Cordero-Reyes AM, Trevino AR, Flores-Arredondo JH, Barrios R, Fernandez-Sada E, Estep JD, Bhimaraj A, Torre-Amione G.

Eur Heart J. 2014 Apr;35(16):1061-8. doi: 10.1093/eurheartj/eht506. Epub 2013 Dec 29.

PMID:
24375073
3.

Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial.

Hindricks G, Packer DL.

Eur Heart J. 2014 Feb;35(8):482-4. doi: 10.1093/eurheartj/eht504. Epub 2013 Dec 25. No abstract available.

4.

Ventricular septal defect originating from an apical left ventricular pseudoaneurysm.

Vontobel J, Hufschmid U, Zellweger MJ, Friedli BC.

Eur Heart J. 2014 May;35(17):1159. doi: 10.1093/eurheartj/eht518. Epub 2013 Dec 25. No abstract available.

PMID:
24371080
5.

Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.

Schmidt S, Hürlimann D, Starck CT, Hindricks G, Lüscher TF, Ruschitzka F, Steffel J.

Eur Heart J. 2014 Apr;35(16):1051-60. doi: 10.1093/eurheartj/eht514. Epub 2013 Dec 25.

PMID:
24371079
6.

Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis.

Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, Agatston A, Blumenthal RS, Nasir K.

Eur Heart J. 2014 Sep 1;35(33):2232-41. doi: 10.1093/eurheartj/eht508. Epub 2013 Dec 23.

7.

Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension.

Santos RD, Duell PB, East C, Guyton JR, Moriarty PM, Chin W, Mittleman RS.

Eur Heart J. 2015 Mar 1;36(9):566-75. doi: 10.1093/eurheartj/eht549. Epub 2013 Dec 23.

8.

Secondary arterial hypertension: when, who, and how to screen?

Rimoldi SF, Scherrer U, Messerli FH.

Eur Heart J. 2014 May 14;35(19):1245-54. doi: 10.1093/eurheartj/eht534. Epub 2013 Dec 23. Review.

PMID:
24366917
9.

Coronary microvascular dysfunction: an update.

Crea F, Camici PG, Bairey Merz CN.

Eur Heart J. 2014 May;35(17):1101-11. doi: 10.1093/eurheartj/eht513. Epub 2013 Dec 23. Review.

10.

Bioresorbable scaffolds: rationale, current status, challenges, and future.

Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P.

Eur Heart J. 2014 Mar;35(12):765-76. doi: 10.1093/eurheartj/eht542. Epub 2013 Dec 23. Review.

PMID:
24366915
11.

Endothelial nitric oxide: protector of a healthy mind.

Katusic ZS, Austin SA.

Eur Heart J. 2014 Apr;35(14):888-94. doi: 10.1093/eurheartj/eht544. Epub 2013 Dec 18. Review.

12.

Biomarkers and acute coronary syndromes: an update.

Mueller C.

Eur Heart J. 2014 Mar;35(9):552-6. doi: 10.1093/eurheartj/eht530. Epub 2013 Dec 18. Review.

PMID:
24357507
13.

Highly sensitive troponins knocking at the door of primary prevention.

Giannitsis E, Katus HA.

Eur Heart J. 2014 Feb;35(5):268-70. doi: 10.1093/eurheartj/eht479. Epub 2013 Dec 18. No abstract available.

PMID:
24357506
14.

Myocardial rupture: asymptomatic cover-up.

Oortman RM, Wagenaar LJ, Verhorst PM.

Eur Heart J. 2014 Apr;35(15):988. doi: 10.1093/eurheartj/eht474. Epub 2013 Dec 18. No abstract available.

PMID:
24357505
15.

Cardiac compression by massive mediastinal haematoma due to bleeding from the ectopic bronchial artery.

Muraoka H, Higashikuni Y, Ando J, Komuro I.

Eur Heart J. 2014 Jun 14;35(23):1567. doi: 10.1093/eurheartj/eht520. Epub 2013 Dec 18. No abstract available.

PMID:
24357504
16.

Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes.

Azoulay L, Dell'Aniello S, Simon TA, Renoux C, Suissa S.

Eur Heart J. 2014 Jul 21;35(28):1881-7. doi: 10.1093/eurheartj/eht499. Epub 2013 Dec 18.

PMID:
24353282
17.

Corevalve prosthesis causes anterior mitral leaflet perforation resulting in severe mitral regurgitation and subsequent endocarditis.

Raschpichler M, Seeburger J, Strasser RH, Misfeld M.

Eur Heart J. 2014 Jun 21;35(24):1587. doi: 10.1093/eurheartj/eht503. Epub 2013 Dec 18. No abstract available.

PMID:
24353281
18.

Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients.

Rapsomaniki E, Shah A, Perel P, Denaxas S, George J, Nicholas O, Udumyan R, Feder GS, Hingorani AD, Timmis A, Smeeth L, Hemingway H.

Eur Heart J. 2014 Apr;35(13):844-52. doi: 10.1093/eurheartj/eht533. Epub 2013 Dec 17.

19.

Excluding a giant coronary aneurysm by implantation of a covered stent.

Possner M, Kaufmann PA, Corti R, Gaemperli O.

Eur Heart J. 2014 May;35(17):1130. doi: 10.1093/eurheartj/eht519. Epub 2013 Dec 16. No abstract available.

20.

The grey zone of truth.

Simoons ML.

Eur Heart J. 2014 Sep 21;35(36):2445-7. doi: 10.1093/eurheartj/eht498. Epub 2013 Dec 17. No abstract available.

PMID:
24347318

Supplemental Content

Loading ...
Support Center